Using Innovation to Accelerate & Optimize Your Drug Manufacturing Scale-up Strategy
The pharmaceutical industry faces unprecedented challenges in bringing life-saving drugs to market while maintaining the highest standards of quality, compliance, and operational efficiency. As companies navigate the complex journey from pre-market development to post-market manufacturing, traditional approaches to drug manufacturing scale-up are proving insufficient to meet evolving demands.
This webinar explores how innovative technologies and strategic approaches are transforming the pharmaceutical manufacturing landscape, enabling companies to accelerate their scale-up processes while optimizing quality outcomes and achieving critical success metrics including operational efficiency, regulatory compliance, supply chain resilience, and enhanced manufacturing experience. We'll explore how AI-enabled Quality by Design (QbD) represents a game-changing approach, with the maturity of artificial intelligence unlocking unprecedented possibilities for pharmaceutical manufacturing.
Key Learning Objectives:
- Identify Strategic Value Drivers: Understand the critical value drivers throughout the pharmaceutical product lifecycle and how to optimize outcomes including operational efficiency, compliance, resilience, and sustainability in manufacturing scale-up strategies
- Leverage AI-Enabled Quality by Design: Learn how artificial intelligence and digital technologies are revolutionizing Quality by Design approaches, enabling more efficient and effective drug manufacturing scale-up processes while maintaining regulatory compliance and product integrity
- Implement Digital Transformation Strategies: Gain insights into digital focus areas for life sciences manufacturing and quality management, including advanced manufacturing techniques, supply chain optimization, and the future roadmap for digital transformation in pharmaceutical operations
Speaker
Joe Goodman
GM Americas, Honeywell Life Sciences
Joe Goodman is the Chief Commercial Officer, Life Sciences for Honeywell Technologies, where his team partners strategically with the company's global clients and prospects, identifying the quality and manufacturing system solutions that best fits their needs. Joe is recognized as a thought leader in the fields of quality systems, regulatory compliance, and the implementation of enterprise software within the Life Sciences manufacturing industry. Before joining Honeywell, Joe spent more than 7 years at Merrill Lynch as a Six Sigma Black Belt. He owes much of his penchant for process and solution design to his time spent in that role. Joe also speaks internationally at Compliance and Manufacturing events.
